Staging for
non-melanoma skin cancer is based on the size of the
cancer, lymph node involvement, and the involvement of underlying structures,
such as muscle or bone. Staging of non-melanoma skin cancer has been classified
by the American Joint Committee on Cancer (AJCC).1 The
AJCC stages are also used in Canada.
- TX: Primary tumour cannot
be assessed.
- T0: No evidence of primary
tumour.
- Tis: Cancer at this stage is
contained in the skin lesion (in situ).
- T1:
Tumour is 2 cm (0.8 in.) or
smaller.
- T2: Tumour is larger than
2 cm (0.8 in.) but smaller than
5 cm (2 in.).
- T3: Tumour is larger than
5 cm (2 in.).
- T4: Tumour size varies but tumour has spread deeply into
muscle,
cartilage, or bone.
After the tumour (T) is staged, the TNM system stages
lymph node involvement (N) to help determine the
treatment options at each stage. Lymph node involvement is staged in the
following way:
- NX: Nearby (regional)
lymph nodes cannot be assessed.
- N0: Cancer
has not spread (metastasized) to nearby lymph nodes.
- N1: Cancer has spread to nearby lymph nodes.
The last part is to determine whether cancer has spread to other
parts of the body (metastasized). The TNM system stages metastasis (M) in the
following way:
- MX: The presence of
distant metastasis cannot be assessed.
- M0:
Cancer has not metastasized.
- M1: Cancer has
metastasized.
The TNM staging system allows your doctor to recommend the most
effective treatment options and discuss your long-term outcome (prognosis)
based on the type of tumour, the stage of the cancer, your age, and your
overall health.
The stage and TNM class are grouped in the following table.
Non-melanoma skin cancer stage and
class| Stage | TNM class |
|---|
Stage 0 | |
Stage I | |
Stage II | |
Stage III | |
Stage IV | |